Program Description: 

The field of Multiple Sclerosis (MS) and related disorders is a very rapidly evolving field of diagnostics and therapeutics. Every year, more treatments become available and new disease entities are being described. It is very difficult for healthcare providers to stay up to date with such changes. Thus, this educational activity aims to provide up to date value education for attendee. There are limited clinical trials in pediatric population with care of children largely being modeled after research and treatment in adult neuroimmunology cases and collaborative efforts are needed to educate both sides as well as the community. Especially that multiple sclerosis and related disorders can present differently in the adult versus pediatric populations. And a gap of knowledge regarding transition of pediatric patients with MS and related disorders to the adult stage in life and what is needed to assure smooth transition of clinical care and disease understanding. Identification of rare neuroimmuniological disease remains an unmet need and helping healthcare providers understand common and rare presentations of such diseases is at the utmost of importance given the potential for rapid and effective treatment.

Key Words: Neurology, Immunology, Multiple Sclerosis, MS, Case, Case-based, Neuroimmunology, Rare Disease, Pediatric, Adult, Identification, Clinical Trials, Effective Treatment

Target audience: 
  • Physicians
  • Fellows/ Residents
  • Advanced Practice Providers
  • Medical Students (No Credit Provided)
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Identify common and uncommon presentations of multiple sclerosis and related disorders
  • Discuss the mechanism of disease modification via current and future therapeutics
  • Identify common manifestations and initial diagnostic work-up of neuroimmunologic disease in children
Faculty & credentials: 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Activity Directors:
Lileth Mondok, MD
Assistant Professor
Associate Medical Director of General Neurology
Division of Pediatric Neurology
Department of Neurology, MCW

Ahmed Obeidat, MD, PhDAlexion, Biogen, BMS, Biologix, EMD Serono, Genentech, TG therapeutics, GW Pharma, Novartis, Celgene, Horizon, Viela Bio
  • Speaker Bureau
  • Consultant
  • Advisory Committee



Brian Cunningham
Series date: 
01/01/2022 - 8:00am CST to 12/31/2022 - 11:59pm CST
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals
Group description: 
Neuroimmunology Conference
Series location: 
Virtual Meeting
Milwaukee, WI 53226
United States


Session Date
Neuroimmunology Conference 2022 01/13/2022 - 12:00pm to 1:00pm CST
Neuroimmunology Conference 2022 04/14/2022 - 12:00pm to 1:00pm CDT
Neuroimmunology Conference 2022 07/14/2022 - 12:00pm to 1:00pm CDT
Neuroimmunology Conference 2022 11/17/2022 - 12:00pm to 1:00pm CST